Skip to content
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
Zumedha | Equity Research

Research · Analysis · Insights

Zumedha | Equity Research

Research · Analysis · Insights

  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Tools
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Tools
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
Close

Search

Zumedha | Equity Research

Research · Analysis · Insights

Zumedha | Equity Research

Research · Analysis · Insights

  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Tools
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Tools
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
Close

Search

Home/Hotels & Hospitality/Lemon Tree Hotels DCF Valuation April 2026
Hotels & Hospitality

Lemon Tree Hotels DCF Valuation April 2026

By Zumedha Research Team on April 28, 2026 11 Min Read
Zumedha Equity ResearchResearch . Analysis . Insights
CMP
₹117
as on 26 Apr 2026
ACCUMULATE
Lemon Tree Hotels
India’s Largest Mid-Market Hotel Chain — Renovating for the Next RevPAR Upcycle
Consumer Discretionary · Hospitality · NSE: LEMONTREE
EQUITY RESEARCH — DEEP VALUE REPORT
26 APRIL 2026
NSELEMONTREE
BSE541233
ISININE970X01018
Face Value₹10
52W H/L₹181 / ₹100
Mkt Cap₹9,300 Cr
Shares79.5 Cr
P/E (TTM)~44x
P/B7.5x
Promoter22.3%
01 Business Overview

Lemon Tree Hotels — founded in 2002, publicly listed since 2018 — is India’s largest hotel chain in the mid-priced segment and the country’s third-largest overall by portfolio. With 269 hotels (131 operational, 138 in pipeline) across 90+ cities and ~21,900+ rooms as of March 2026, Lemon Tree is uniquely positioned at the intersection of India’s rapidly growing middle class and the structural undersupply of quality branded mid-market accommodation.

The company’s seven-brand portfolio spans the full mid-to-upper market spectrum: Aurika Hotels & Resorts (upper upscale), Lemon Tree Premier (upscale), Lemon Tree Hotels (upper midscale), Red Fox by Lemon Tree (midscale/economy), and the Keys family — Keys Prima, Keys Select, and Keys Lite — which together form the franchise engine for asset-light expansion into Tier 2 and Tier 3 cities. Aurika Mumbai International Airport (MIAL) is the flagship property, now stabilising at ~70% occupancy with premium ARR of ₹9,000+.

A defining Lemon Tree differentiator is its Inclusive Employment Programme — over 30% of the workforce comprises specially-abled individuals, ex-convicts, and marginalised communities — creating a genuine cost efficiency advantage (lower attrition, government incentives) alongside ESG credentials. The company has been in active portfolio renovation mode through FY24–FY26, a deliberate investment cycle expected to lift ARR by ₹1,300–₹1,400 per room post-renovation in key markets. Management targets ₹1,000 Cr EBITDA by FY28 and is executing an organised demerger of Fleur Hotels (the asset-heavy vehicle) from Lemon Tree (the asset-light operating entity), which should unlock significant value.

TTM Revenue
₹1,407 Cr
Screener TTM consolidated
Q3 FY26 Revenue
₹408 Cr
All-time high; +15% YoY
Net EBITDA Margin
50.6%
Q3 FY26; best-in-class mid-market
Q3 FY26 PAT
₹82 Cr
+2% YoY; renovation drag
Q3 FY26 ARR
₹7,487
+11% YoY
Q3 FY26 RevPAR
₹5,494
+9% YoY; occ. 73.4%
Portfolio Mar-26
269
Hotels; 131 operational, 138 pipeline
FY28E EBITDA Target
₹1,000 Cr
Management guidance
02 Historical Financials

Lemon Tree’s financials reflect a sharp post-COVID recovery (FY23–FY25), followed by a deliberate investment cycle in renovation (FY25–FY26) that temporarily compresses PAT growth despite strong revenue momentum. The key thesis is a post-renovation profit inflection from FY27 onwards. The company runs a high-EBITDA-margin (Net EBITDA 50%+), moderate PAT margin business due to significant depreciation and interest costs from its asset-heavy owned hotel base — a structure that is being addressed via the Fleur Hotels demerger.

⚠ Key Balance Sheet Alert — Debt Profile
~₹1,640 Cr
Down from ₹1,890 Cr (FY24); active repayment
~1.5x
Elevated but declining; target zero in 4 years
~3.2x
Improving; was 11x in FY22 post-COVID
~3.8x
Healthy; rising with EBITDA growth
~₹440 Cr
IND AS 116; largely fixed, long-duration
Zero
Management commitment by FY29E
Metric (₹ Crore, Consol.)FY22FY23FY24FY259M FY26FY26EFY27E
Revenue from Operations4028751,0661,2841,0721,4701,655
Revenue Growth YoY+60%+118%+22%+21%+15%~15%E~13%E
Net EBITDA~95~350~490~620~535~720~850
Net EBITDA Margin23.6%40%46%48.3%49.9%49%E51%E
Depreciation + Amort.~230~240~260~285~220~300~325
EBIT-135110230335315420525
Finance Costs~145~140~150~138~100~130~110
PBT-280-3080197215290415
PAT (Consol.)-2405105210~182280350
PAT Marginnm0.6%9.8%16.4%17.0%19%E21%E
EPS (₹, Consol.)-3.00.061.322.65~2.293.52E4.40E
Gross ARR (₹)~4,200~5,200~6,100~6,500~7,200~7,800E~9,500E

* 9M FY26 estimates based on Q1 FY26 (₹268 Cr), Q2 FY26 (₹308 Cr, standalone), Q3 FY26 (₹408 Cr, consolidated). FY25 revenue from MOFSL estimates (₹1,284 Cr = INR 12,841 Mn). EBITDA margins on “Net EBITDA” basis (after rent, before D&A, interest). FY27E ARR assumes post-renovation portfolio uplift. Zumedha estimates; not audited.

03 DCF Valuation — 10-Year Free Cash Flow

The DCF for Lemon Tree is more nuanced than a pure luxury player: the high EBITDA margins (~50%) are partially offset by elevated debt service and renovation capex in the near term. We use a higher WACC of 12.5% reflecting the leveraged balance sheet, and a terminal growth rate of 5.5% aligned with India’s mid-market hospitality long-run CAGR. The post-renovation FCF inflection (FY27–FY28) is the key value unlock in the DCF model.

DCF Assumptions & Key Inputs
WACC
12.5%
Higher vs. peers; reflects D/E ~1.5x
Terminal Growth Rate
5.5%
Mid-market India hospitality CAGR
Projection Period
10 Yrs
FY26E–FY35E
Revenue CAGR (FY26–30E)
14%
Reno uplift + pipeline keys
EBITDA Margin (Normalised)
50–52%
Post-reno; operational leverage
Maintenance Capex
1.8% Rev
Post-reno normalised; per management
Tax Rate
25.2%
Effective; new regime
Shares Outstanding
79.5 Cr
As at Apr 2026
DCF Intrinsic Value per Share
Sum of PV of FCFs (FY26–35E) + Terminal Value, net of net debt ~₹1,640 Cr
₹128
+9% upside from CMP ₹117

Sensitivity: At WACC 13.0% / TGR 5.0%, DCF ~₹105. At WACC 12.0% / TGR 6.0%, DCF ~₹155. The wide range underscores the debt sensitivity in the model. Debt reduction over FY26–29 is a direct catalyst for DCF value expansion; every ₹500 Cr of debt reduction adds ~₹6 per share.

04 Relative Valuation & Peer Multiples

Lemon Tree trades at an interesting juncture: its P/E of 44× appears elevated on FY26E earnings, but drops to a more digestible 27× on FY27E estimates. The stock’s premium P/B (7.5×) to some peers reflects its franchise value and EBITDA margin superiority. Critically, at 18× FY27E EV/EBITDA, Lemon Tree screens cheaper than IHCL on most metrics and in line with Chalet Hotels, despite offering higher organic growth and a more differentiated mid-market brand.

CompanyMkt Cap (₹Cr)Revenue TTMNet EBITDA%EV/EBITDA FY27EP/E TTMP/BNet D/ERating
Lemon Tree (LEMONTREE)9,300₹1,407 Cr50–51%18x~44x7.5x~1.5xACCUMULATE
IHCL (Indian Hotels)1,10,000+₹9,700 Cr37–38%27x72x10xNet CashHOLD / REDUCE
ITC Hotels (ITCHOTELS)32,900₹3,946 Cr36–37%20x44.6x3.1xNet CashACCUMULATE
EIH Ltd (Oberoi)28,000₹2,100 Cr38–40%19x31x4.8xNet CashBUY
Chalet Hotels9,500₹1,200 Cr32–34%18x55x3.6x~1.2xHOLD

Lemon Tree’s superior Net EBITDA margin (50%+) vs. Chalet (32–34%) reflects the asset-light management fee income contribution and lower-cost employee model. The leverage differential vs. ITC Hotels and EIH is the key valuation gap; as debt reduces, expect P/B compression and P/E normalisation.

05 Asset-Based / NAV Valuation

Lemon Tree’s NAV is complicated by the mixed owned/leased/managed structure and significant lease liabilities under IND AS 116. Owned hotel properties (primarily Aurika MIAL, Aurika Mumbai, and the Delhi/Hyderabad owned assets) carry meaningful real estate value, but this is partially offset by the debt on the balance sheet. The planned Fleur Hotels demerger will sharpen the NAV clarity of the listed entity significantly.

NAV Build-Up — Conservative Estimate (per share)
Owned Hotel Properties (est. replacement value, select assets)₹6,800 Cr
Management & Franchise Contract Portfolio (20× fee income)₹2,800 Cr
Brand Value (7 brands; Aurika, Lemon Tree Premier, Keys)₹1,400 Cr
Aurika Nehru Place Land + Aurika Shimla (under construction)₹500 Cr
Less: Net Debt (FY25 ~₹1,640 Cr) + Lease Liabilities (~₹440 Cr)-₹2,080 Cr
NAV per Share (79.5 Cr shares)₹117–₹128

The fact that CMP (₹117) is essentially at NAV suggests the market is ascribing near-zero franchise premium to Lemon Tree’s operating business. This is historically unusual for a growing chain with 50%+ EBITDA margins. The Fleur demerger could re-rate NAV significantly by separating real estate liabilities from the operating business.

06 Earnings Power Value (EPV)

EPV on FY26E normalised EBIT of ₹420 Cr, post-tax NOPAT ~₹314 Cr, capitalised at WACC 12.5%, yields an EPV of ~₹2,510 Cr for the operating business. Deducting net debt (~₹1,640 Cr) and lease liabilities (~₹440 Cr), and dividing by 79.5 Cr shares gives EPV per share of ~₹5. As with ITC Hotels, the near-zero EPV per share demonstrates that the market is paying purely for growth. For Lemon Tree, this growth bet is concentrated on: (a) post-renovation ARR uplift, (b) pipeline hotel additions, and (c) debt reduction releasing earnings leverage. All three are executable but require 2–3 years to fully materialise.

07 Sum-of-the-Parts (SOTP) Valuation
SOTP — Lemon Tree Hotels Consolidated
Owned & Leased Hotels (18× FY27E EBITDA contribution)₹7,200 Cr
Fleur Hotels (subsidiary; owned properties excl. from above)₹2,800 Cr
Management & Franchise fees (20× FY27E fee income ~₹160 Cr)₹3,200 Cr
Keys brand portfolio (12× EBITDA contribution)₹800 Cr
Development pipeline (50 hotels; option value)₹500 Cr
Less: Net Debt + Lease Liabilities-₹2,080 Cr
SOTP Enterprise Value → Per Share₹12,420 Cr → ₹156

SOTP of ₹156/share implies ~33% upside from CMP. The wide gap between current market price and SOTP reflects the market’s discount for execution risk on the renovation programme and debt reduction. Motilal Oswal’s SoTP-based target price of ₹185 is more aggressive, assuming faster post-renovation ARR lift and Fleur demerger premium.

08 Buy Range Framework
STRONG BUY
Below ₹100
At or below 52W low (~₹100). Below NAV, at 14× FY27E P/E. Aggressive accumulation.
ACCUMULATE
₹100 – ₹135
CMP ₹117 falls here. Staggered SIP entry. ~27–33% upside to 12M target over 2–3 years.
FAIR VALUE
₹135 – ₹160
Hold existing positions. New entry requires high conviction on renovation delivery + FY28 EBITDA.

At CMP ₹117, Lemon Tree is in our Accumulate zone, having corrected ~35% from its 52-week high of ₹181. The stock is trading near the lower end of its 52-week range and just above its technical support zone of ₹100–105. The ongoing renovation investment cycle is a temporary PAT drag — a deliberate strategy, not a sign of structural deterioration. Investors willing to look through 2–3 quarters of muted PAT growth are likely to be rewarded as the renovation-led ARR uplift flows through from FY27 onwards.

09 Buy Scenario Analysis
Bear Case
₹85
  • Renovation delays push ARR uplift to FY28+
  • RevPAR growth decelerates to <5% on demand weakness
  • Debt reduction stalls; interest cost remains elevated
  • Fleur demerger faces regulatory delays or fails
  • ~27% downside from CMP; P/E compresses to 22×
Base Case
₹155
  • Revenue CAGR 14% FY26–28E; margins stable at 49–51%
  • Post-reno ARR up ₹1,300–₹1,400/room from FY27
  • Net debt down to ₹900–1,000 Cr by FY28E
  • EBITDA crosses ₹900 Cr in FY28; PAT ₹380–400 Cr
  • ~32% upside from CMP over 12–18 months
Bull Case
₹200
  • Fleur demerger re-rates the asset-light LTH entity to 25× EV/EBITDA
  • ARR post-renovation exceeds ₹10,000 across portfolio
  • Debt reduction ahead of schedule; net cash by FY29
  • International expansion (Dubai etc.) adds new earnings stream
  • ~71% upside from CMP; PE re-rates to 45× FY28E
10 Sell Range Framework
REDUCE
₹170 – ₹190
Book 30–40% of holdings. At >22× EV/EBITDA (FY27E). Near 52W high territory.
EXIT
₹190 – ₹215
Full exit for conviction-light holders. Above SOTP + full franchise premium.
AVOID ENTRY
Above ₹215
Pricing in full FY28 recovery + Fleur demerger premium. Reward/risk unfavourable.
11 Sell Scenario — When to Exit
Overvalued Signal
₹175+
  • EV/EBITDA exceeds 22× before renovation uplift is confirmed
  • P/E > 50× on FY27E without earnings beat
  • Stock outperforms sector by >40% in 6 months
Exit Trigger
On Events
  • Promoter (Patanjali Keswani) pledging increases significantly
  • FY27 EBITDA misses ₹850 Cr management guidance by >15%
  • Renovation ARR lift materialises below ₹800/room
  • Fleur demerger cancelled or indefinitely postponed
  • Net debt rises rather than falls in FY27
Structural Break
Exit All
  • Demand collapse: occupancy falls below 55% sustained
  • Mid-market disruption by OYO/Airbnb at scale erodes ARR
  • Debt covenant breach / rating downgrade triggering refinancing
  • Management transition creates strategic uncertainty
12 Future Growth Outlook

Lemon Tree is executing on three simultaneous growth engines: renovation-led ARR uplift in the existing portfolio, aggressive asset-light expansion through management and franchise contracts (Keys brand), and the planned Fleur Hotels demerger that will crystallise separate valuation for the asset-heavy and asset-light businesses. The FY28 EBITDA target of ₹1,000 Cr (vs. ~₹720 Cr in FY26E) is ambitious but grounded.

Renovation-Led ARR Uplift

Over 65% of the older portfolio renovated by Q3 FY26. Post-renovation, Delhi ARR rose 15% and Hyderabad 19%. Remaining ~1,200 rooms renovation expected by FY27. At completion, aggregate portfolio ARR could rise by ₹1,300–₹1,400/room with occupancy uplift of ~10 percentage points — a powerful double-leverage on RevPAR.

Asset-Light Scaling (Keys)

17 new management and franchise contracts signed in Q3 FY26 alone, adding 1,855 rooms. The Keys brand (Prima/Select/Lite) targets Tier 2/3 cities with sub-₹200 Cr total investment per hotel. Management fees from third-party hotels grew 24% YoY in Q3 FY26, demonstrating the asset-light flywheel is already spinning.

Aurika Upper-Upscale Expansion

Aurika Mumbai International Airport (occupancy ~70%, ARR ₹9,000+) is the proof-of-concept for the upper-upscale segment. Aurika Shimla (2 blocks by Q2 FY27), Aurika Nehru Place (Delhi; land allotted), and a Varanasi heritage property in the pipeline signal premium positioning at higher margin rates than core Lemon Tree hotels.

Fleur Hotels Demerger Value

Fleur Hotels holds the company’s owned/leased asset-heavy properties. The planned demerger from Lemon Tree Hotels will create two separately listed entities — a pure-play asset-light hospitality management company (LTH) and a REIT-adjacent real estate hospitality company (Fleur). This structural simplification could re-rate LTH toward 25–30× EV/EBITDA, matching global asset-light hotel management company multiples.

UDAN 2.0 & Airport Hotel Opportunity

Budget 2026’s UDAN 2.0 scheme adding 50+ new airports creates addressable mid-market hotel demand in previously underserved catchments. With Aurika MIAL as the template, Lemon Tree is well-positioned to replicate airport-adjacent premium hotels in Tier 2 aviation hubs where supply is nearly zero.

Debt Reduction → Earnings Leverage

Every ₹500 Cr of debt repaid saves ~₹40–45 Cr in annual interest cost, flowing directly to PAT. Management has committed to net debt zero by FY29E. This creates a powerful PAT CAGR of 30–35% in FY26–28E even on modest revenue growth — making Lemon Tree a rare debt-deleveraging + revenue growth story simultaneously.

13 Risks & Catalysts
↑ Bull Catalysts
  • Fleur Hotels demerger approval triggers structural re-rating to 25×+ EV/EBITDA
  • Q4 FY26 / Q1 FY27 post-renovation ARR data confirms ₹1,300+ lift per room
  • Net debt drops below ₹1,000 Cr in FY27E; improving interest coverage
  • Management fees crossing ₹150 Cr annualised; asset-light model credibility
  • Aurika Shimla opens on schedule — high RevPAR leisure property validates expansion
  • Index inclusion (Nifty Midcap 150) triggers passive inflows
  • International expansion (Dubai/Southeast Asia) adds new earnings stream
  • Occupancy sustains above 75% post-renovation across the owned portfolio
↓ Bear Risks
  • Promoter pledge risk — any pledge calls create forced selling overhang
  • Renovation overrun — cost escalation or further delays push ARR uplift to FY28+
  • Mid-market supply glut in Bangalore, Hyderabad, Pune — key Lemon Tree markets
  • OYO / Airbnb scaling in the ₹4,000–₹7,000 ARR range compresses RevPAR
  • GST rate changes on mid-market hospitality (policy risk)
  • Corporate travel budget cuts in economic slowdown — mid-market most exposed
  • Fleur demerger complications leading to balance sheet complexity
  • Key management transition risk as CMD Patanjali Keswani transitions to Executive Chairman
— Blended Valuation Summary
DCF (10-yr FCF)
₹128
Weight: 25%
Peer EV/EBITDA
₹155
Weight: 30%
Asset-Based NAV
₹122
Weight: 15%
EPV
₹5
Weight: 5%
SOTP
₹156
Weight: 25%
BLENDED TARGET
₹148
12-Month Price Target
Investment Verdict — Zumedha Equity Research
Lemon Tree Hotels is a compelling but nuanced mid-cycle accumulate. The stock offers exposure to India’s fastest-growing mid-market hospitality segment at a price that is essentially at NAV — an unusual setup for a quality branded chain with 50%+ EBITDA margins. The near-term PAT drag from deliberate renovation investment is masking the true earnings power of the renovated portfolio, which management’s own track record suggests will materialise sharply from FY27. The Fleur demerger, if executed, is a binary re-rating catalyst. The primary risk is balance sheet — ₹1,640 Cr of debt is manageable but leaves little room for revenue disappointment. We assign ACCUMULATE at a 12-month blended target of ₹148 (~26% upside from CMP ₹117). Staggered entry is recommended; consider averaging down if the stock revisits ₹100–105 on market weakness, which would offer a compelling margin of safety.
ACCUMULATE
12-Month Target
₹148
~+26% upside from CMP ₹117
Disclaimer: This report is produced by Zumedha Equity Research for informational and educational purposes only. It does not constitute investment advice or a solicitation to buy or sell any securities. The analysis is based on publicly available information, company filings, broker research (MOFSL, Keynote, Dolat Capital), and third-party data believed to be reliable but not independently verified. Zumedha Equity Research and its analysts may or may not hold positions in the securities mentioned. Past performance is not a guarantee of future results. Equity investments are subject to market risk. Investors should conduct their own due diligence and consult a SEBI-registered investment advisor before making any investment decision. CMP as of 26 April 2026. All financial estimates are Zumedha projections unless otherwise stated.
Author

Zumedha Research Team

Follow Me
Other Articles
Previous

KPIT Technologies Share Price Analysis April 2026

Next

Axis Bank Share DCF Value Analysis April 2026

Legal Disclaimer Investment Research & Information

Not Investment Advice. All content published on this website — including stock analyses, mutual fund reviews, DCF models, valuation estimates, buying zones, and commentary — is created for our own educational, internal research and informational purposes only. Nothing on this website constitutes financial, investment, legal, or tax advice, nor a solicitation or recommendation to buy, sell, or hold any security or financial instrument.

No Guarantees. It is advised clearly and categorically not o follow these analysis and information blindly for your equity investement purpose as Equity investments and mutual funds are subject to market risks. Past performance is not indicative of future results. All DCF models, fair value estimates, and scenario analyses are based on publicly available data and the author's independent assumptions and may prove materially incorrect. The author/s or owners of this website/portal do not are not liable in whatsoever manner for any positive or negative outcome from your own investment endeavorsYou may lose part or all of your invested capital.

Do Your Own Research. Readers are strongly advised to consult a SEBI-registered investment advisor and conduct their own due diligence before making any investment decision. The author may or may not hold positions in securities discussed on this website.

No Obligations. We, the author/ the publisher/ anybody associated with Zumedha.com does not guarantee the accuracy, adequacy or completeness of any information/data and is not responsible for any errors or omissions or for the results obtained from the use of such information/data. Zumedha.com or anyone involved with zumedha.com will not accept any liability for loss or damage as a result of reliance on the Estimates data. It does not subscribe or endorse any of the services and/or content offered by such third party.

Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
This website is not registered as an Investment Adviser under SEBI (Investment Advisers) Regulations, 2013. All views are personal and for informational purposes only.
© 2026 · All Rights Reserved · For Educational Use Only. RESEARCH · ANALYSIS · INSIGHTS